Table 1.
n (%) | |
---|---|
Socio-demographics | |
Age (years; mean ± SDa; range: 27–77) | 48.26 ± 10.40 |
Education Level | |
Primary and below | 90 (20.9) |
Secondary | 278 (64.5) |
Tertiary | 63 (14.6) |
Marital status | |
Married | 425 (98.6) |
Other marital status | 6 (1.4) |
Has children | |
Yes | 416 (96.5) |
No | 15 (3.5) |
Employment status | |
Unemployed | 170 (39.4) |
Retired | 54 (12.5) |
Employed | 207 (48.1) |
Average monthly income over the past 12 months (Chinese Yuan) | |
< 3000 | 170 (39.4) |
3000–6000 | 194 (45.0) |
6001–9000 | 52 (12.1) |
> 9000 | 15 (3.5) |
Place of residence | |
Urban | 207 (48.0) |
Rural | 224 (52.0) |
Chronic disease (disease course > 6 months) | |
Yes | 28 (6.5) |
No | 403 (93.5) |
Clinical characteristics | |
Illness stage | |
0–I | 134 (31.1) |
II | 203 (47.1) |
III | 66 (15.3) |
IV | 28 (6.5) |
Metastasis | |
No metastasis | 285 (66.1) |
Axillary | 119 (27.6) |
Other metastasis | 27 (6.3) |
Surgical style | |
No surgery | 146 (33.9) |
Modified radical mastectomy | 203 (47.1) |
Simple mastectomy | 60 (13.9) |
Breast conservation | 23 (5.3) |
Adjuvant therapy | |
Conventional chemotherapy | 381 (88.4) |
Neoadjuvant chemotherapy | 26 (6.0) |
Radio therapy | 151 (35.0) |
Endocrine therapy | 231 (53.6) |
Targeted therapy | 47 (10.9) |
HRQoLb (mean ± SD) | |
Physical well-being | 17.75 ± 4.91 |
Social/family well-being | 17.66 ± 5.95 |
Emotional well-being | 14.29 ± 4.48 |
Functional well-being | 13.24 ± 5.04 |
Breast-cancer-specific | |
Subscales for additional concerns | 24.81 ± 3.97 |
FACT-Bv4.0c Total Score | 87.74 ± 18.69 |
Resilience (mean ± SD) | |
Tenacity | 27.51 ± 8.19 |
Self-reliance | 16.84 ± 4.42 |
Optimism | 10.37 ± 3.06 |
CD-RISCd total score | 54.72 ± 14.71 |
Perceived social support (mean ± SD) | |
Family support | 24.16 ± 3.24 |
Friends’ support | 20.76 ± 4.00 |
Significant others’ support | 20.52 ± 4.17 |
MSPSSe total score | 65.45 ± 9.40 |
Coping style (mean ± SD) | |
Confrontation | 19.87 ± 3.73 |
Avoidance | 16.70 ± 1.90 |
Resignation | 9.57 ± 2.87 |
aSD: standard deviation
bHealth-related quality of life
cFunctional assessment of cancer therapy-breast version 4.0
dConnor–Davidson resilience scale
eMultidimensional scale of perceived social support